• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WWC1 和 NF2 通过调节 LATS 在小鼠中抑制 YAP/TAZ 活性从而预防肝内胆管细胞癌的发生。

WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.

机构信息

Department of Biological Sciences, National Creative Research Initiatives Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.

Department of Pathology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul 06273, Korea.

出版信息

Mol Cells. 2020 May 31;43(5):491-499. doi: 10.14348/molcells.2020.0093.

DOI:10.14348/molcells.2020.0093
PMID:32451369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7264477/
Abstract

Hippo signaling acts as a tumor suppressor pathway by inhibiting the proliferation of adult stem cells and progenitor cells in various organs. Liver-specific deletion of Hippo pathway components in mice induces liver cancer development through activation of the transcriptional coactivators, YAP and TAZ, which exhibit nuclear enrichment and are activated in numerous types of cancer. The upstream-most regulators of Warts, the ortholog of mammalian LATS1/2, are Kibra, Expanded, and Merlin. However, the roles of the corresponding mammalian orthologs, WWC1, FRMD6 and NF2, in the regulation of LATS1/2 activity and liver tumorigenesis are not fully understood. Here, we show that deletion of both and in the liver accelerates intrahepatic cholangiocarcinoma (iCCA) development through activation of YAP/TAZ. Additionally, biliary epithelial cell-specific deletion of both and using a Sox9-Cre system resulted in iCCA development through hyperactivation of YAP/TAZ. These findings suggest that WWC1 and NF2 cooperate to promote suppression of cholangiocarcinoma development by inhibiting the oncogenic activity of YAP/TAZ via LATS1/2.

摘要

Hippo 信号通路通过抑制各种器官中成体干细胞和祖细胞的增殖来发挥肿瘤抑制作用。在小鼠中特异性敲除 Hippo 通路成分会通过激活转录共激活因子 YAP 和 TAZ 诱导肝癌的发生,YAP 和 TAZ 在多种类型的癌症中表现出核富集和激活。Warts 的上游调控因子,即哺乳动物 LATS1/2 的同源物,是 Kibra、Expanded 和 Merlin。然而,相应的哺乳动物同源物 WWCl、FRMD6 和 NF2 在调节 LATS1/2 活性和肝肿瘤发生中的作用尚未完全阐明。在这里,我们表明,肝脏中 WWCl 和 NF2 的缺失通过激活 YAP/TAZ 加速了肝内胆管细胞癌(iCCA)的发展。此外,使用 Sox9-Cre 系统特异性敲除胆管上皮细胞中的 WWCl 和 NF2 导致 iCCA 的发展,这是通过 YAP/TAZ 的过度激活实现的。这些发现表明,WWC1 和 NF2 通过抑制 YAP/TAZ 的致癌活性,与 LATS1/2 合作促进了胆管癌的发展。

相似文献

1
WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.WWC1 和 NF2 通过调节 LATS 在小鼠中抑制 YAP/TAZ 活性从而预防肝内胆管细胞癌的发生。
Mol Cells. 2020 May 31;43(5):491-499. doi: 10.14348/molcells.2020.0093.
2
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.一种YAP/TAZ诱导的反馈机制调节Hippo信号通路的稳态。
Genes Dev. 2015 Jun 15;29(12):1271-84. doi: 10.1101/gad.262816.115.
3
The Hippo pathway member Nf2 is required for inner cell mass specification.Hippo 通路成员 NF2 对于内细胞团的特化是必需的。
Curr Biol. 2013 Jul 8;23(13):1195-201. doi: 10.1016/j.cub.2013.05.044. Epub 2013 Jun 20.
4
Two Hippo signaling modules orchestrate liver size and tumorigenesis.两个 Hippo 信号模块协调肝脏大小和肿瘤发生。
EMBO J. 2023 Jun 1;42(11):e112126. doi: 10.15252/embj.2022112126. Epub 2023 Mar 15.
5
Tumor suppressor LATS1 is a negative regulator of oncogene YAP.肿瘤抑制因子LATS1是致癌基因YAP的负调控因子。
J Biol Chem. 2008 Feb 29;283(9):5496-509. doi: 10.1074/jbc.M709037200. Epub 2007 Dec 24.
6
Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.肿瘤抑制因子 Nf2 通过抑制 Yap/Taz 转录共激活因子来限制神经祖细胞池的扩增。
Development. 2013 Aug;140(16):3323-34. doi: 10.1242/dev.096537. Epub 2013 Jul 17.
7
Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.跨膜蛋白 KIRREL1 通过反馈环调节 Hippo 信号通路,是 YAP/TAZ 活性癌症的治疗靶点。
Cell Rep. 2022 Aug 30;40(9):111296. doi: 10.1016/j.celrep.2022.111296.
8
Stabilization of Motin family proteins in NF2-deficient cells prevents full activation of YAP/TAZ and rapid tumorigenesis.NF2 缺陷细胞中 Motin 家族蛋白的稳定可防止 YAP/TAZ 的完全激活和肿瘤的快速发生。
Cell Rep. 2021 Aug 24;36(8):109596. doi: 10.1016/j.celrep.2021.109596.
9
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.Sox2拮抗Hippo信号通路以维持癌细胞的干性。
Nat Commun. 2015 Apr 2;6:6411. doi: 10.1038/ncomms7411.
10
A critical role for NF2 and the Hippo pathway in branching morphogenesis.NF2 和 Hippo 通路在分支形态发生中的关键作用。
Nat Commun. 2016 Aug 2;7:12309. doi: 10.1038/ncomms12309.

引用本文的文献

1
OMVs inhibit osteogenic differentiation of BMSCs via SAA3/TLR4/MyD88/NF-κB axis.外膜囊泡通过血清淀粉样蛋白A3/ Toll样受体4/髓样分化因子88/核因子κB轴抑制骨髓间充质干细胞的成骨分化。
J Oral Microbiol. 2025 Aug 8;17(1):2540823. doi: 10.1080/20002297.2025.2540823. eCollection 2025.
2
Dietary Palmitic Acid Drives a Palmitoyltransferase ZDHHC15-YAP Feedback Loop Promoting Tumor Metastasis.膳食棕榈酸驱动棕榈酰转移酶ZDHHC15-YAP反馈环促进肿瘤转移。
Adv Sci (Weinh). 2025 Feb;12(6):e2409883. doi: 10.1002/advs.202409883. Epub 2024 Dec 16.
3
The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling.

本文引用的文献

1
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.原发性肝癌中 YAP 和 TAZ 的异质性:其预后和诊断作用分析。
Int J Mol Sci. 2019 Feb 1;20(3):638. doi: 10.3390/ijms20030638.
2
YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC.YAP/TAZ 通过上调 MYC 引发胃肿瘤发生。
Cancer Res. 2018 Jun 15;78(12):3306-3320. doi: 10.1158/0008-5472.CAN-17-3487. Epub 2018 Apr 18.
3
Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
组蛋白赖氨酸乙酰转移酶 KAT2B 抑制胆管癌生长:与 SP1 相互作用以调节 NF2-YAP 信号的证据。
J Exp Clin Cancer Res. 2024 Apr 19;43(1):117. doi: 10.1186/s13046-024-03036-5.
4
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.肿瘤发生发展中的癌胚重编程:癌症治疗的新见解
MedComm (2020). 2023 Dec 2;4(6):e427. doi: 10.1002/mco2.427. eCollection 2023 Dec.
5
Two Hippo signaling modules orchestrate liver size and tumorigenesis.两个 Hippo 信号模块协调肝脏大小和肿瘤发生。
EMBO J. 2023 Jun 1;42(11):e112126. doi: 10.15252/embj.2022112126. Epub 2023 Mar 15.
6
Glyoxalase 1 as a Therapeutic Target in Cancer and Cancer Stem Cells.糖氧醛酸 1 作为癌症和癌症干细胞治疗靶点。
Mol Cells. 2022 Dec 31;45(12):869-876. doi: 10.14348/molcells.2022.0109. Epub 2022 Sep 28.
7
TAOK1 Promotes Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells by Inhibition of WWC1.TAOK1 通过抑制 WWC1 促进非小细胞肺癌细胞的增殖和侵袭。
Comput Math Methods Med. 2022 Sep 15;2022:3157448. doi: 10.1155/2022/3157448. eCollection 2022.
8
YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma.YAP1 激活与 Hippo 通路信号在肝内胆管癌发病机制及治疗中的作用。
Adv Cancer Res. 2022;156:283-317. doi: 10.1016/bs.acr.2022.02.003. Epub 2022 Mar 9.
9
DNMBP-AS1 Regulates NHLRC3 Expression by Sponging miR-93-5p/17-5p to Inhibit Colon Cancer Progression.DNMBP-AS1 通过海绵吸附 miR-93-5p/17-5p 调控 NHLRC3 表达以抑制结肠癌进展。
Front Oncol. 2022 Apr 27;12:765163. doi: 10.3389/fonc.2022.765163. eCollection 2022.
10
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.Hippo 通路与癌症:YAP/TAZ 和 TEAD 作为癌症治疗靶点。
Clin Sci (Lond). 2022 Feb 11;136(3):197-222. doi: 10.1042/CS20201474.
MORC2 通过表观遗传限制 Hippo 信号通路从而成为肝癌细胞干性的基础。
Cell Death Differ. 2018 Dec;25(12):2086-2100. doi: 10.1038/s41418-018-0095-6. Epub 2018 Mar 19.
4
YAP-associated chromosomal instability and cholangiocarcinoma in mice.YAP相关的染色体不稳定性与小鼠胆管癌
Oncotarget. 2017 Dec 22;9(5):5892-5905. doi: 10.18632/oncotarget.23638. eCollection 2018 Jan 19.
5
Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.Hippo 通路共激活因子 Yap 和 Taz 对于协调哺乳动物肝脏再生是必需的。
Exp Mol Med. 2018 Jan 5;50(1):e423. doi: 10.1038/emm.2017.205.
6
Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development.NF2 在神经上皮隔室中的差异表达对于哺乳动物眼睛发育是必需的。
Dev Cell. 2018 Jan 8;44(1):13-28.e3. doi: 10.1016/j.devcel.2017.11.011. Epub 2017 Dec 14.
7
WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.WW 和 C2 结构域蛋白通过 hippo 信号通路调节肝实质细胞分化和肿瘤发生。
Hepatology. 2018 Apr;67(4):1546-1559. doi: 10.1002/hep.29647. Epub 2018 Feb 18.
8
Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.肝内胆管癌中胆小管细胞分化特征的转录组学和组织病理学分析。
Liver Int. 2018 Jan;38(1):113-124. doi: 10.1111/liv.13492. Epub 2017 Jul 10.
9
Kibra and Merlin Activate the Hippo Pathway Spatially Distinct from and Independent of Expanded.Kibra和Merlin在空间上与Expanded不同且独立地激活Hippo信号通路。
Dev Cell. 2017 Mar 13;40(5):478-490.e3. doi: 10.1016/j.devcel.2017.02.004.
10
LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development.LATS-YAP/TAZ 通过调节 TGFβ 信号和 Hnf4α 表达在肝发育过程中控制谱系特化。
Nat Commun. 2016 Jun 30;7:11961. doi: 10.1038/ncomms11961.